🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
Evaluate the safety, tolerability, and objective response rate (ORR) of SHR...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-09
Trial ID
NCT07175220
Treatments Being Tested
This is a multi-center phase II/III clinical study consisting of two stages...
Status
Terminated
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-01-26
Trial ID
NCT05149807
Treatments Being Tested
This is an open label, multi-center, phase I/II study to evaluate the effic...
Status
Unknown
Location
Cancer Hospital of Guangzhou Sun Yat-sen University
Start Date
2021-09
Trial ID
NCT05020925
This is an open label, phase Ib Study of SHR-1701 in patients with recurren...
Status
Unknown
Location
Cancer Hospital of Guangzhou Sun Yat-sen University
Start Date
2020-03-27
Trial ID
NCT04282070
Treatments Being Tested
This clinical study aims to evaluate the efficacy and safety of Retlirafusp...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-08
Trial ID
NCT07749859
Treatments Being Tested
The study is being conducted to evaluate safety, tolerability, pharmacokine...
Status
Unknown
Location
Henan Science and Technology University First Affiliated Hospital
Start Date
2022-02-22
Trial ID
NCT05198817
Treatments Being Tested
To evaluate the tolerability, safety, pharmacokinetic characteristics and i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05503888
Treatments Being Tested